Results for tag: "Vidaza"

Vidaza is an oncology drug used to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). It is a pyrimidine nucleoside analog that works by inhibiting the growth of cancer cells. It is administered intravenously and is available in both capsule and injection form. Vidaza is approved by the US Food and Drug Administration (FDA) and is marketed by Celgene Corporation. The Vidaza market is a rapidly growing segment of the oncology drug market. It is used to treat a variety of blood cancers, including MDS and AML. It is also used to treat other types of cancer, such as chronic myelomonocytic leukemia (CMML) and myeloproliferative neoplasms (MPN). The drug is widely used in the US and Europe, and is gaining popularity in other parts of the world. The Vidaza market is highly competitive, with several major players. These include Celgene Corporation, Novartis, Pfizer, and Merck. Other companies in the market include Bristol-Myers Squibb, AstraZeneca, and Johnson & Johnson. Show Less Read more